Improvement in health-related quality of life after lung transplantation

Canadian Respiratory Journal

Volumn 16, Issue 5, 2009, Pages 153-158

  Santana, Maria Jose ^a   Feeny, David ^b   Jackson, Katherine ^a   Weinkauf, Justin ^a   Lien, Dale ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Adherence; Health utility index; Health related quality of life; Lung transplantation; Mental health

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EMPLOYMENT STATUS; EXERCISE TOLERANCE; FEMALE; FIBROSING ALVEOLITIS; HEALTH UTILITIES INDEX; HEALTH UTILITIES INDEX MARK 3; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG TRANSPLANTATION; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 70350546005     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/843215     Document Type: Article

References (26)

1. . J Heart Lung Transplant 2007;26:782-95.
2. Lung transplant: A treatment for life-threatening lung disease. (Version current at May 19, 2009).
3. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI®): Concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54.
4. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40:113-28.
5. Grootenstorst P, Feeny D, Furlong W. Health Utility Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000;38:290-9.
6. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001;33:344-9.
7. Feeny D, Furlong W, Saigal S, Sun J. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: Group- and individual-level comparisons. Soc Sci Med 2004;58:799-809.
8. Statistics Canada. National Population Health Survey Cycle 3 Documentation. Catalog # 82-567.
9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
10. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes 2003;1:29.
11. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Applied Sport Sciences 1985;10:141-6.
12. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
13. Feeny D, Wu L, Eng K. Comparing Short Form 6D, Standard Gamble, and Health Utilities Index Mark 2 and Mark3 Utility Scores: Results from total hip arthroplasty patients. Qual Life Res 2004;13:1659-70.
14. Ten Vergert E, Essink-Bot ML, Geertsma A, van Enckevort P, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: A longitudinal study. Chest 1998;113:358-64.
15. Limbos M, Joyce D, Chan C, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000;118:408-16.
16. Lanuza D, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E Jr. Prospective study of fuctional status and quality of life before and after lung transplantation. Chest 2000;118:115-22.
17. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001;56:218-22.
18. Parekh P, Blumenthal J, Babyak MA, et al. Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest 2003;124:1682-8.
19. Dew MA. Psychiatric disorder in the context of physical illness. In Dohrenwend BP, ed. Adversity, Stress and Psychopathology. Washington, DC: Elsevier Science, 1998.
20. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998;113:633-44.
21. Rodrigue JR, Baz MA, Kanasky WF, MacNaughton KL. Does transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005;24:755-63.
22. Desmyttere A, Dobbles F, Clecemput I, De Geest S. Noncompliance with immunosuppressive regimen in organ transplantation: Is it worth worrying about? Act Gastroenterol Belg 2005;68:347-52.
23. Denhaerynck A, Stagier J, Block A, et al. Prevalence and risk factors of nonadherence with immunosuppresive medication in kidney transplant patients. Am J Transplant 2007;7:108-16.
24. Littlefield C, Abbey S, Fiducia D, et al. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry 1996;18:36S-47S.
25. Stavern K, Bjortuft O, Lund MB, Kongshaung K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000;67:159-65.
26. Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation: A 7-year comparison to functional outcome. Chest 2005;128:1371-8.